Belgium· BE-AMP-SAM508897-00
Pregabaline Apotex 300 mg
A pregabalin product containing pregabalin, registered in Belgium by Apotex Europe. The same ATC class is registered in 3 of our 19 countries.
Checked against FAMHP / AFMPS (Belgium) on
Informational only — not a medical device.
Where it is registered
Pregabalin is registered in 3 of 19 countries.
Countries holding a registration under ATC N03AX16 (pregabalin), each read from that country’s own register.
- This record: Belgium, from FAMHP / AFMPS (Belgium)
- 2 of them publish a price we can compare per daily dose
Pregabalin · ATC N03AX16
3 / 19 countries
- Belgiumprice
- Ireland
- Polandprice
The record
At a glance
FAMHP / AFMPS (Belgium)- Active substance
- Pregabalin
- Manufacturer
- Apotex Europe
- Country
- Belgium (BE)
- ATC code
- N03AX16
- ATC class
- Pregabalin
- Reimbursed
- Not published by this register
- Source register
- FAMHP / AFMPS (Belgium)
- Last checked
- September 26, 2026
Packs & prices · 4
- be_apb7721913
- be_apb3682697
- be_apb3682689
- be_apb3682705
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Interactions
282 interactions on record for pregabalin.
Graded by severity as the source publishes them — 4 severe. Severity grades are free for everyone; mechanism and management come with Growth.
- Severity for every pair — free, no plan needed
- The source, licence and sync date on every record
- Mechanism and what to do for each pair — Growth plan
Pregabalin · interactions on record
282 records
- 4 severe
- 60 moderate
- 180 info
Most severe, free to view
- MorphineN02AA01severe
- MorphinN07BC09severe
- HydrocodoneR05DA03severe
- CodeineR05DA04severe
38 more interactions with mechanism and management, from a commercially licensed source.
Sign in to check- Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.
Same medicine, other countries
Pregabalin in 17 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- CzechiaKARTESADAEgis Pharmaceuticals PLC, Budapešť
- United StatesLyricaParke-Davis Div of Pfizer Inc
- SpainACIRYL 300 MG CAPSULAS DURAS EFGNeuraxpharm Spain S.L.U.
- United KingdomAlzain 300mg capsulesDr Reddy's Laboratories (UK) Ltd
- SwedenBrieka 300 mg Kapsel, hårdTeva B.V.
- FinlandBriekaActavis Group PTC ehf
- NetherlandsLinefor 300 mg, harde capsulesPharmaceutical Works Polpharma S.A.
- CanadaACH-PREGABALINACCORD HEALTHCARE INC
Authorised across Europe · EMA
The same active substance is authorised in 30 EEA countries. Names it is sold under:
- Austria · Lynagex, Lynagex 165 Mg
- Bulgaria · Pregabin, Бриека
- Cyprus · Epibal, Grabilen
- Czechia · Kartesada, Naxalgan
- Germany · Pregabador, Pregabahexal
- Denmark · Galberin, Lyribastad
- Estonia · Brieka, Bulgaplin
- Spain · Aciryl, Apregia
- Finland · Lyribastad, Pregabalin Grindeks
- France · Lexenu, Lexenu 75 Mg
- United Kingdom (Northern Ireland) · Alzain, Avellar
- Greece · Algecia, Apregalin
- Croatia · Pragiola, Pregabalin Belupo
- Hungary · Kartesada, Naxalgan
- Ireland · Pregabalin Basics, Pregabalin Brillpharma (Ireland)
- Iceland · Brieka, Lyrica
- Italy · Aclaton, Ecubalin
- Liechtenstein · Lyrica, Pregabalin Accord
- Lithuania · Brieka, Bulgaplin
- Luxembourg · Pregabalin Micro Labs, Pregabaline Eg
- Latvia · Brieka, Bulgaplin
- Malta · Epibal, Pragiola
- Netherlands · Dalingo, Linefor
- Norway · Lyrica, Pregabalin 1a Farma
- Poland · Bulgaplin, Egzysta
- Portugal · Kartesada, Lygabrin
- Romania · Lynagex, Pragiola
- Sweden · Brieka, Bulgaplin
- Slovenia · Pragiola, Pregabalin Grindeks
- Slovakia · Kartesada, Naxalgan
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of FAMHP / AFMPS (Belgium). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/e6a2cdb0-dcad-4ef7-93d4-2dbdc5db18ce GET /v1/drugs/e6a2cdb0-dcad-4ef7-93d4-2dbdc5db18ce?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Capsule, hard",
"source": "afmps",
"status": "REVOKED",
"name_en": "Pregabaline Apotex 300 mg",
"name_fr": "Pregabaline Apotex 300 mg",
"name_nl": "Pregabaline Apotex 300 mg",
"amp_code": "SAM508897-00",
"strengths": [
"300.0000",
"300.0000",
"108.0000",
"0.0768"
],
"pack_count": 3,
"substances": [
"Pregabalin",
"Lactose Monohydrate",
"Sodium Laurilsulfate"
],
"medicine_type": "ALLOPATHIC",
"atc_description": "Pregabalin",
"authorisation_numbers": [
"BE508897"
]
}See everything about pregabalin.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.